Revenue
2013
2014
2015
2016
2017
Tempest Therapeutics, Inc. (TPST)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $295,000 | $653,000 | $277,000 | $0 | $0 | — |
| Research & development | $12.6M | $28.5M | $17.5M | $22.5M | $17.2M | $14.4M | $27.8M | $14.4M | $14.5M | $21.6M | $18.4M | $21.8M | $15.8M | $6.3M |
| Operating expenses | — | — | — | — | — | — | — | — | $50.9M | $81.7M | $72.3M | $47.9M | $29.1M | $13.5M |
| Operating income | −$26.6M | −$42.0M | −$29.2M | −$34.6M | −$27.0M | −$19.3M | −$45.4M | −$26.9M | −$84.3M | −$81.0M | −$72.0M | −$47.9M | −$29.1M | −$13.5M |
| EBITDAderived | — | — | — | — | — | — | — | — | −$82.7M | −$78.8M | −$70.7M | −$47.5M | −$28.9M | −$13.4M |
| Net income | −$26.3M | −$41.8M | −$29.5M | −$35.7M | −$28.3M | −$19.2M | −$44.6M | −$27.2M | −$84.6M | −$82.3M | −$73.2M | −$49.5M | −$29.0M | −$13.5M |
| Basic EPSper diluted share | -$6.33 | -$19.50 | -$1.91 | -$3.09 | -$7.47 | -$41.03 | -$3.25 | -$17.58 | -$321.81 | -$2.56 | -$2.70 | -$2.19 | -$1.80 | -$2.33 |
| Diluted EPSper diluted share | -$6.33 | -$19.50 | -$1.91 | -$3.09 | -$7.47 | -$41.03 | -$3.25 | -$17.58 | -$321.81 | -$2.56 | -$2.70 | -$2.19 | -$1.80 | -$2.33 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 24, 2026Form 4 | Angel MatthewCEO and President | BuyCommon Stock · indirect | 231.5K | $2.16 | $500.0K | 231.5K |
| Mar 24, 2026Form 4 | Angel MatthewCEO and President | BuySeries B Warrant (right to buy) · derivative · indirect | 231.5K | — | — | 231.5K |
| Mar 24, 2026Form 4 | Angel MatthewCEO and President | BuySeries A Warrant (right to buy) · derivative · indirect | 231.5K | — | — | 231.5K |
| Mar 24, 2026Form 4 | Angel MatthewCEO and President | BuyCommon Stock · indirect | 231.5K | $2.16 | $500.0K | 231.5K |
| Aug 12, 2024Form 4 | Versant Venture Capital VI, L.P. +8TenPercentOwner | SellCommon Stock | 388.0K | $1.10 | $426.8K | 209.9K |